pyruvaldehyde has been researched along with Dementia in 2 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, W | 1 |
Uribarri, J | 1 |
Zhu, L | 1 |
Chen, X | 1 |
Swamy, S | 1 |
Zhao, Z | 1 |
Grosjean, F | 1 |
Simonaro, C | 1 |
Kuchel, GA | 1 |
Schnaider-Beeri, M | 1 |
Woodward, M | 1 |
Striker, GE | 1 |
Vlassara, H | 1 |
Lovestone, S | 1 |
Smith, U | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Dietary Reduction of Advanced Glycation End Products to Prevent Cognitive Decline in Elderly Diabetics - a Randomized Pilot Trial[NCT02739971] | 75 participants (Actual) | Interventional | 2016-06-30 | Completed | |||
Effects of Glycoxidative Stress on Human Aging[NCT00579774] | 438 participants (Actual) | Interventional | 2007-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 other studies available for pyruvaldehyde and Dementia
Article | Year |
---|---|
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.
Topics: ADAM Proteins; ADAM10 Protein; Administration, Oral; Aged; Amyloid beta-Peptides; Amyloid Precursor | 2014 |
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.
Topics: ADAM Proteins; ADAM10 Protein; Administration, Oral; Aged; Amyloid beta-Peptides; Amyloid Precursor | 2014 |
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.
Topics: ADAM Proteins; ADAM10 Protein; Administration, Oral; Aged; Amyloid beta-Peptides; Amyloid Precursor | 2014 |
Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans.
Topics: ADAM Proteins; ADAM10 Protein; Administration, Oral; Aged; Amyloid beta-Peptides; Amyloid Precursor | 2014 |
Advanced glycation end products, dementia, and diabetes.
Topics: Animals; Dementia; Female; Glycation End Products, Advanced; Humans; Male; Metabolic Syndrome; Pyruv | 2014 |